Role of STAT3 in Resistance of Non-small Cell Lung Cancer

by Sibo SUN, Shidai JIN, Renhua GUO
Published 2019-07-01

Clinical Observation of Gefitinib with Pericardial Perfusion for 
Advanced Non-small Cell Lung Cancer

by Xiaomeng WANG, Jin CHEN, Jiaqi YAO, Renhua GUO
Published 2018-01-01

Concurrent use of anlotinib overcomes acquired resistance to EGFR‐TKI in patients with advanced EGFR‐mutant non‐small cell lung cancer

by Chen Zhang, Honggang Cao, Yanan Cui, Shidai Jin, Wen Gao, Chenjun Huang, Renhua Guo
Published 2021-10-01

Janus kinase 2 polymorphisms are associated with risk in patients with gastric cancer in a Chinese population.

by Li Yang, Dongxiao Liu, Song Liang, Renhua Guo, Zhihong Zhang, Hao Xu, Chao Yang, Yi Zhu
Published 2013-01-01

Clinical Study of Erlotinib in the Treatment of Patients with Advanced Stage Non-small Cell Lung Cancer

by Renhua GUO, Yongqian SHU, Yongmei YIN, Xiaodong LI, Hua SHEN, Wen GAO, Jing SUN, Tongshan WANG
Published 2009-12-01

Gefitinib or erlotinib as maintenance therapy in patients with advanced stage non-small cell lung cancer: a systematic review.

by Xiaofeng Chen, Yiqian Liu, Oluf Dimitri Røe, Yingying Qian, Renhua Guo, Lingjun Zhu, Yongmei Yin, Yongqian Shu
Published 2013-01-01

IL-22 Confers EGFR-TKI Resistance in NSCLC via the AKT and ERK Signaling Pathways

by Xiaomeng Wang, Xiaomeng Wang, Jiali Xu, Jin Chen, Shidai Jin, Jiaqi Yao, Tongfu Yu, Wei Wang, Renhua Guo
Published 2019-11-01

Clinical significance of ERBB2 exon 16 skipping: analysis of a real-world retrospective observational cohort study

by Xue Wu, Lei Shi, Yang Shao, Caihua Xu, Yutong Ma, Qiuxiang Ou, Songhua Lu, Renhua Guo, Jinliang Kong
Published 2020-12-01

LINC00665 Induces Acquired Resistance to Gefitinib through Recruiting EZH2 and Activating PI3K/AKT Pathway in NSCLC

by Xinyin Liu, Xiyi Lu, Fuxi Zhen, Shidai Jin, Tongfu Yu, Quan Zhu, Wei Wang, Kun Xu, Jiaqi Yao, Renhua Guo
Published 2019-06-01

EZH2-Mediated Epigenetic Suppression of GDF15 Predicts a Poor Prognosis and Regulates Cell Proliferation in Non-Small-Cell Lung Cancer

by Xiyi Lu, Xuezhi He, Jun Su, Jing Wang, Xinyin Liu, Kun Xu, Wei De, Erbao Zhang, Renhua Guo, Yuenian Eric Shi
Published 2018-09-01

The Role of FGFR1 Gene Amplification as a Poor Prognostic Factor in Squamous Cell Lung Cancer: A Meta-Analysis of Published Data

by Yang Wang, Wen Gao, Jiali Xu, Xiaojun Chen, Yang Yang, Yizhi Zhu, Yongmei Yin, Renhua Guo, Ping Liu, Yongqian Shu, Lingxiang Liu
Published 2015-01-01

Efficacy and acquired resistance of EGFR-TKI combined with chemotherapy as first-line treatment for Chinese patients with advanced non-small cell lung cancer in a real-world settin...

by Qianqian Wang, Wen Gao, Fangyan Gao, Shidai Jin, Tianyu Qu, Fan Lin, Chen Zhang, Jingya Zhang, Zhihong Zhang, Liang Chen, Renhua Guo
Published 2021-05-01

Identification of Germline Mismatch Repair Gene Mutations in Lung Cancer Patients With Paired Tumor-Normal Next Generation Sequencing: A Retrospective Study

by Sibo Sun, Yiqian Liu, Ann-Kathrin Eisfeld, Fuxi Zhen, Shidai Jin, Wen Gao, Tongfu Yu, Liang Chen, Wei Wang, Wei Chen, Mingming Yuan, Rongrong Chen, Kai He, Renhua Guo
Published 2019-06-01

Icotinib is an active treatment of non-small-cell lung cancer: a retrospective study.

by Xiaofeng Chen, Quan Zhu, Yiqian Liu, Ping Liu, Yongmei Yin, Renhua Guo, Kaihua Lu, Yanhong Gu, Lianke Liu, Jinghua Wang, Zhaoxia Wang, Oluf Dimitri Røe, Yongqian Shu, Lingjun Zhu
Published 2014-01-01

High Expression of ACE2 and TMPRSS2 at the Resection Margin Makes Lung Cancer Survivors Susceptible to SARS-CoV-2 With Unfavorable Prognosis

by Qianqian Wang, Liangyu Li, Liangyu Li, Tianyu Qu, Jie Li, Jie Li, Lingxiang Wu, Lingxiang Wu, Kening Li, Kening Li, Ziyu Wang, Ziyu Wang, Mengyan Zhu, Mengyan Zhu, Bin Huang, Bin Huang, Wei Wu, Wei Wu, Min Wu, Min Wu, Rong Ding, Rong Ding, Zhihong Zhang, Qianghu Wang, Qianghu Wang, Xinyi Xia, Xinyi Xia, Xinyi Xia, Pengping Li, Pengping Li, Zhi Zhang, Renhua Guo
Published 2021-05-01